Evaluating the Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity Using a Biomarker Cocktail in Healthy Human Volunteers

Trial Profile

Evaluating the Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity Using a Biomarker Cocktail in Healthy Human Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Sep 2014

At a glance

  • Drugs Tipranavir (Primary) ; Tipranavir (Primary) ; Caffeine; Dextromethorphan; Digoxin; Digoxin; Midazolam; Midazolam; Omeprazole; Ritonavir; Vitamin K; Warfarin
  • Indications HIV-1 infections
  • Focus Biomarker; Pharmacokinetics
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 22 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top